Therapeutic effects of interleukin-1 receptor antagonist on allergic rhinitis of guinea pig

Acta Pharmacologica Sinica

Volumn 24, Issue 3, 2003, Pages 251-255

  Zhang, Hong Quan ^a   Sun, Yun ^a   Xu, Feng ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Histamine; IgE; Interleukin 1 receptors; Perennial allergic rhinitis

Indexed keywords

HISTAMINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACUTE PHASE RESPONSE; ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE ACTIVATION; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DRUG EFFECT; HISTAMINE RELEASE; HISTOPATHOLOGY; IMMUNE RESPONSE; MEDIATOR RELEASE; NONHUMAN; NOSE CONGESTION; NOSE MUCOSA; RAT; TARGET CELL;

ANIMALS; FEMALE; GUINEA PIGS; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; NASAL MUCOSA; RECEPTORS, INTERLEUKIN-1; RHINITIS, ALLERGIC, PERENNIAL; SIALOGLYCOPROTEINS; TOLUENE 2,4-DIISOCYANATE;

EID: 0037334931     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993; 48: 476-90.
2. Naclerio RM, Proid D, Togias AG, Togias AG, Adkinson NF Jr, Meyers DA, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313: 65-70.
3. Benson M, Strannegard IL, Wennergren G, Strannegard O. Increase of the soluble IL-4 receptor (IL-4sR) and positive correlation between IL-4sR and IgE in nasal fluids from school children with allergic rhinitis. Allergy Asthma Proc 2000; 21: 89-95.
4. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 2000; 105: S599-604.
5. Pearlman DS. Pathophysiology of the inflammatory response. J Allergy Clin Immunol 1999; 104 (4 Pt 1): S132-7.
6. Ohkawa C, Ukai K, Miyahara Y, Takeuchi K, Sakakura Y. Histamine H1 receptor and reactivity of the nasal mucosa in sensitized guinea pigs. Auris Nasus Larynx 1999; 26: 293-8.
7. Masamoto T, Ohashi Y, Nakai Y. Specific immunoglobulin E, interleukin-4, and soluble vascular cell adhesion molecule-1 in sera in patients with seasonal allergic rhinitis. Ann Otol Rhinol Laryngol 1999; 108: 169-76.
8. Christodoulopoulos P, Cameron L, Durham S, Hamid Q. Molecular pathology of allergic disease. II: Upper airway disease. J Allergy Clin Immunol 2000; 105: 211-23.
9. Bachert C, Van Kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999; 118: 375-9.
10. Opal SM, DePalo VA. Anti-inflammatory cytokines [see comments]. Chest 2000; 117: 1162-72.
11. Rosenwasser LJ. Biologic activities of IL-1 and its role in human disease. J Allergy Clin Immunol 1998; 102: 344-50.
12. Zhao XJ, Deng Z, Yang ZQ. Establishment of rhinitis model. China J Octirhinolaryngol 1993; 28: 17-8.
13. Xu SY, Bian RL, Chen X. Experimental methods in pharmacology. 3rd ed. Beijing: People's Medical Publishing House; 2002. p 476.
14. Marone G, Granata F, Spadaro G. Anti-inflammatory effects of oxatomide. J Investig Allergol Clin Immunol 1999; 9: 207-14.
15. Lorentz-A, Schwengberg S, Sellge G, Manns MP, Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol 2000; 164: 43-8.
16. Urushibara T, Uesugi K, Yoshino K, Kubota N, Takeyama I. Pollinosis etiologic relationship between excessive IL-4 production and down-regulation of the inflammation-suppressive system. Acta Otolaryngol Suppl 1996; 522: 68-73.
17. Bachert C, Wagenmann M, Hauser U. Proinflammatory cytokines: measurement in nasal secretion and induction of adhesion receptor expression. Int Arch Allergy Immunol 1995; 107: 106-8.